The Essure device was implanted into women’s fallopian tubes to prevent pregnancy. It left some women with chronic pelvic ...

Rising demand for preventive healthcare and rapidly ageing populations around the world have boosted the global medical ...

The official spokesperson for the Ministry of Health and Population, Hossam Abdel-Ghaffar, said the “Your Heart is Your Responsibility” campaign, which aims to raise awareness about cardiovascular ...

Swiss immune-oncology specialist Anaveon has appointed Richard Sachse as its chief medical officer (CMO) effective February 1 ...

GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on ...

Bayer announced positive topline results from the global phase III QUASAR study evaluating ... Detailed results will be submitted to regulatory authorities worldwide and presented at upcoming medical ...

Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Richard Sachse, M.D., Ph.D., as Chief Medical Officer effective February 1, 2025. Dr. Sachse brings more than 25 ...

That evidence drew on a wide range of medical and scientific disciplines. Justice Keogh found for Bayer, noting pelvic pain and abnormal uterine bleeding are common in pre-menopausal women, and there ...

Regeneron Pharmaceuticals REGN announced that it has met the primary endpoint in a late-stage study evaluating Eylea HD ...

Dexcom’s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.

BASEL, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced the appointment of ...

A new law firm has opened up shop in the prominent intersection near U.S. Highway 280 and Interstate 459. Jennings & Earley ...